BioSpace News Archive

Drug Development

AstraZeneca’s Evusheld Successfully Prevents Progression to Severe COVID-19

Results of the Phase III trial showed that Evusheld protected against progression to severe COVID-19 or death in the early outpatient treatment of mild-to-moderate COVID-19.

June 8, 2022
·
3 min read
·
Hannah Chudleigh
Drug Development

Global Roundup: Denmark’s Ascendis Sees “Real Control” in Hypothyroidism

At ENDO 2022, Ascendis will share Phase II and III data showing clinical efficacy for its investigational product candidate for hypoparathyroidism. For this and more, see inside.

June 8, 2022
·
7 min read
·
Alex Keown
Business

Astellas Makes Big Commitment to Gene Therapy with New NC Facility

The new space will enable Astellas to establish a global supply chain of gene therapies as well as widen the scope of the therapeutic products it creates.

June 8, 2022
·
3 min read
·
Hannah Chudleigh
Drug Development

Disparate Geographical Data from Rigel Anemia Trial “Confound” Investigator

South San Francisco-based Rigel Pharmaceuticals reported its Phase III Forward trial of fostamatinib did not show statistical significance in warm autoimmune hemolytic anemia

June 8, 2022
·
3 min read
·
Mark Terry
Drug Development

Annexon Engages the Target, Sees Stabilization in Phase II Huntington’s Trial

Annexon released final data from an open-label phase II clinical trial, showing that its drug candidate ANX005 safely stabilized disease progression in patients with Huntington’s disease.

June 8, 2022
·
3 min read
·
Tristan Manalac
Drug Development

Sanofi Celebrates Latest Dupixent Approval, Cambridge Crossing Opening

The approval expands the rapidly growing number of indications for Dupixent, which is the first and only biologic medication with the FDA’s nod to treat atopic dermatitis from infancy to adulthood.

June 8, 2022
·
2 min read
·
Vanessa Doctor, RN
Researchers Report Gene Therapy May Correct Creatine Deficiency Disorder

UCLA researchers report gene therapy may correct a rare creatine deficiency disorder that results in intellectual disabilities, issues with speech, involuntary movements and recurrent seizures.

June 8, 2022
·
2 min read
·
Jazmine Colatriano
Business

Actor Greg Grunberg Discusses New Series: “The Care Giver”

Greg Grunberg, who has appeared in multiple Star Wars projects, has partnered with Jazz Pharmaceuticals to bring “The Care Giver”, a video web series, to life.

June 8, 2022
·
4 min read
·
Alex Keown
Chest Drainage Application is Expected to Drive the Drainage Bottles Demand, With an Absolute Dollar Opportunity of US$ 223 Mn, Reveals Fact.MR

Drainage bottles market is getting significant traction from hospitals and clinics are gaining utmost traction because of the availability of specialized staff and individualized treatment approaches.

June 8, 2022
·
6 min read
Wearable Heart Monitoring Devices Market Analysis by Top Key Players and Overview 2026

Wilmington, Delaware, United States: A wearable heart rate monitor is a personal monitoring device.

June 8, 2022
·
6 min read